Akums Drugs and Pharmaceuticals Limited
Akums Drugs and Pharmaceuticals Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: AKUMS and BSE: 544222 (ISIN INE09XN01023).
It has a market capitalisation of ₹10,864 crore, a last close of ₹709.55 on 2026-10-19, a one-year return of 53.7%.
Valuation: a price-to-earnings ratio of 37.24x, a price-to-book ratio of 3.28x, a dividend yield of 0.1%.
Profitability: return on equity of 8.0%, return on capital employed of 12.6%, an operating margin of 12.6%.
Balance sheet and ownership: debt-to-equity of 0.02x, promoter holding of 75.3%.
| Metric | Value |
|---|---|
| Market capitalisation | 10,864 |
| Last close | ₹709.55 |
| P/E (TTM) | 37.24x |
| P/B | 3.28x |
| Dividend yield | 0.1% |
| ROE (FY) | 8.0% |
| ROCE (FY) | 12.6% |
| Operating margin (TTM) | 12.6% |
| Debt / equity | 0.02x |
| Promoter holding | 75.3% |
| 1-year return | 53.7% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means